Breast cancer is divided into luminal A, luminal B, HER2-overexpressing and basal-like subtypes according to their differential expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2–6]. This evidence concerns the gene PGR and breast carcinoma.